Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 4486 entries
Sorted by: Best Match Show Resources per page
Comparison of remnant to total functional liver volume ratio and remnant to standard liver volume ratio as a predictor of postoperative liver function after liver resection.

Korean journal of hepato-biliary-pancreatic surgery

Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Cho CK, Kim HJ.
PMID: 26155230
Korean J Hepatobiliary Pancreat Surg. 2013 Nov;17(4):143-51. doi: 10.14701/kjhbps.2013.17.4.143. Epub 2013 Nov 20.

BACKGROUNDS/AIMS: The future liver remnant (FLR) is usually calculated as a ratio of the remnant liver volume (RLV) to the total functional liver volume (RLV/TFLV). In liver transplantation, it is generally accepted that the ratio of the graft volume...

Cite
Kim HJ, Kim CY, Hur YH, et al. Comparison of remnant to total functional liver volume ratio and remnant to standard liver volume ratio as a predictor of postoperative liver function after liver resection. Korean J Hepatobiliary Pancreat Surg. 2013;17(4):143-51doi: 10.14701/kjhbps.2013.17.4.143.
Kim, H. J., Kim, C. Y., Hur, Y. H., Koh, Y. S., Kim, J. C., Cho, C. K., & Kim, H. J. (2013). Comparison of remnant to total functional liver volume ratio and remnant to standard liver volume ratio as a predictor of postoperative liver function after liver resection. Korean journal of hepato-biliary-pancreatic surgery, 17(4), 143-51. https://doi.org/10.14701/kjhbps.2013.17.4.143
Kim, Hee Joon, et al. "Comparison of remnant to total functional liver volume ratio and remnant to standard liver volume ratio as a predictor of postoperative liver function after liver resection." Korean journal of hepato-biliary-pancreatic surgery vol. 17,4 (2013): 143-51. doi: https://doi.org/10.14701/kjhbps.2013.17.4.143
Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Cho CK, Kim HJ. Comparison of remnant to total functional liver volume ratio and remnant to standard liver volume ratio as a predictor of postoperative liver function after liver resection. Korean J Hepatobiliary Pancreat Surg. 2013 Nov;17(4):143-51. doi: 10.14701/kjhbps.2013.17.4.143. Epub 2013 Nov 20. PMID: 26155230; PMCID: PMC4304515.
Copy Download .nbib Format: NLM
Evaluation of Antioxidant and Hepatoprotective Activities of Moringa oleifera Lam. Leaves in Carbon Tetrachloride-Intoxicated Rats.

Antioxidants (Basel, Switzerland)

Singh D, Arya PV, Aggarwal VP, Gupta RS.
PMID: 26785072
Antioxidants (Basel). 2014 Sep 02;3(3):569-91. doi: 10.3390/antiox3030569.

The antioxidant and hepatoprotective activities of the extract of Moringa oleifera leaves were investigated against CCl₄-induced hepatotoxicity in rats. Hepatotoxic rats were treated with ethanol extract of Moringa oleifera for a period of 60 days at the following three...

Cite
Singh D, Arya PV, Aggarwal VP, et al. Evaluation of Antioxidant and Hepatoprotective Activities of Moringa oleifera Lam. Leaves in Carbon Tetrachloride-Intoxicated Rats. Antioxidants (Basel). 2014;3(3):569-91doi: 10.3390/antiox3030569.
Singh, D., Arya, P. V., Aggarwal, V. P., & Gupta, R. S. (2014). Evaluation of Antioxidant and Hepatoprotective Activities of Moringa oleifera Lam. Leaves in Carbon Tetrachloride-Intoxicated Rats. Antioxidants (Basel, Switzerland), 3(3), 569-91. https://doi.org/10.3390/antiox3030569
Singh, Dharmendra, et al. "Evaluation of Antioxidant and Hepatoprotective Activities of Moringa oleifera Lam. Leaves in Carbon Tetrachloride-Intoxicated Rats." Antioxidants (Basel, Switzerland) vol. 3,3 (2014): 569-91. doi: https://doi.org/10.3390/antiox3030569
Singh D, Arya PV, Aggarwal VP, Gupta RS. Evaluation of Antioxidant and Hepatoprotective Activities of Moringa oleifera Lam. Leaves in Carbon Tetrachloride-Intoxicated Rats. Antioxidants (Basel). 2014 Sep 02;3(3):569-91. doi: 10.3390/antiox3030569. PMID: 26785072; PMCID: PMC4665414.
Copy Download .nbib Format: NLM
Efficacy of tolvaptan in patients with refractory ascites in a clinical setting.

World journal of hepatology

Ohki T, Sato K, Yamada T, Yamagami M, Ito D, Kawanishi K, Kojima K, Seki M, Toda N, Tagawa K.
PMID: 26140088
World J Hepatol. 2015 Jun 28;7(12):1685-93. doi: 10.4254/wjh.v7.i12.1685.

AIM: To elucidate the efficacies of tolvaptan (TLV) as a treatment for refractory ascites compared with conventional treatment.METHODS: We retrospectively enrolled 120 refractory ascites patients between January 1, 2009 and September 31, 2014. Sixty patients were treated with oral...

Cite
Ohki T, Sato K, Yamada T, et al. Efficacy of tolvaptan in patients with refractory ascites in a clinical setting. World J Hepatol. 2015;7(12):1685-93doi: 10.4254/wjh.v7.i12.1685.
Ohki, T., Sato, K., Yamada, T., Yamagami, M., Ito, D., Kawanishi, K., Kojima, K., Seki, M., Toda, N., & Tagawa, K. (2015). Efficacy of tolvaptan in patients with refractory ascites in a clinical setting. World journal of hepatology, 7(12), 1685-93. https://doi.org/10.4254/wjh.v7.i12.1685
Ohki, Takamasa, et al. "Efficacy of tolvaptan in patients with refractory ascites in a clinical setting." World journal of hepatology vol. 7,12 (2015): 1685-93. doi: https://doi.org/10.4254/wjh.v7.i12.1685
Ohki T, Sato K, Yamada T, Yamagami M, Ito D, Kawanishi K, Kojima K, Seki M, Toda N, Tagawa K. Efficacy of tolvaptan in patients with refractory ascites in a clinical setting. World J Hepatol. 2015 Jun 28;7(12):1685-93. doi: 10.4254/wjh.v7.i12.1685. PMID: 26140088; PMCID: PMC4483550.
Copy Download .nbib Format: NLM
Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B.

Hepatology international

Lin B, Pan CQ, Xie D, Xie J, Xie S, Zhang X, Wu B, Lin C, Gao Z.
PMID: 26201778
Hepatol Int. 2013 Jun;7(2):460-7. doi: 10.1007/s12072-012-9415-y. Epub 2013 Feb 11.

BACKGROUND: The mortality of acute-on-chronic hepatitis B liver failure (ACHBLF) from acute exacerbation of chronic hepatitis B is 30-70 % without liver transplant.METHODS: We conducted an open-label, prospective, 48-week study to evaluate the efficacy of entecavir (ETV) in ACHBLF...

Cite
Lin B, Pan CQ, Xie D, et al. Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B. Hepatol Int. 2013;7(2):460-7doi: 10.1007/s12072-012-9415-y.
Lin, B., Pan, C. Q., Xie, D., Xie, J., Xie, S., Zhang, X., Wu, B., Lin, C., & Gao, Z. (2013). Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B. Hepatology international, 7(2), 460-7. https://doi.org/10.1007/s12072-012-9415-y
Lin, Bingliang, et al. "Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B." Hepatology international vol. 7,2 (2013): 460-7. doi: https://doi.org/10.1007/s12072-012-9415-y
Lin B, Pan CQ, Xie D, Xie J, Xie S, Zhang X, Wu B, Lin C, Gao Z. Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B. Hepatol Int. 2013 Jun;7(2):460-7. doi: 10.1007/s12072-012-9415-y. Epub 2013 Feb 11. PMID: 26201778.
Copy Download .nbib Format: NLM
Remnant left liver size and recovery of living right liver donors.

Hepatology international

Fong YK, Chan SC, Cheung TT, Dai WC, Chok KS, Chan AC, Sharr WW, Lo CM.
PMID: 26201808
Hepatol Int. 2013 Jun;7(2):734-40. doi: 10.1007/s12072-012-9410-3. Epub 2012 Nov 14.

PURPOSE: Living donor liver transplantation is a realistic life-saving treatment in regions where deceased donor organs are scarce. The minimum remnant left liver volume (RLLV) requirement for donor right hepatectomy (DRH) varies in different programs of living donor liver...

Cite
Fong YK, Chan SC, Cheung TT, et al. Remnant left liver size and recovery of living right liver donors. Hepatol Int. 2012;7(2):734-40doi: 10.1007/s12072-012-9410-3.
Fong, Y. K., Chan, S. C., Cheung, T. T., Dai, W. C., Chok, K. S., Chan, A. C., Sharr, W. W., & Lo, C. M. (2013). Remnant left liver size and recovery of living right liver donors. Hepatology international, 7(2), 734-40. https://doi.org/10.1007/s12072-012-9410-3
Fong, Yuen Ki, et al. "Remnant left liver size and recovery of living right liver donors." Hepatology international vol. 7,2 (2013): 734-40. doi: https://doi.org/10.1007/s12072-012-9410-3
Fong YK, Chan SC, Cheung TT, Dai WC, Chok KS, Chan AC, Sharr WW, Lo CM. Remnant left liver size and recovery of living right liver donors. Hepatol Int. 2013 Jun;7(2):734-40. doi: 10.1007/s12072-012-9410-3. Epub 2012 Nov 14. PMID: 26201808.
Copy Download .nbib Format: NLM
Correlation of pre- and post-operative liver function, duct diameter at porta hepatis, and portal fibrosis with surgical outcomes in biliary atresia.

Journal of Indian Association of Pediatric Surgeons

Baruah RR, Bhatnagar V, Agarwala S, Gupta SD.
PMID: 26628810
J Indian Assoc Pediatr Surg. 2015 Oct-Dec;20(4):184-8. doi: 10.4103/0971-9261.161040.

BACKGROUND AND AIMS: Extrahepatic biliary atresia is one of the most challenging conditions in pediatric surgery. The definition of prognostic factors is controversial. Surgical outcomes after bilioenteric drainage procedures are variable. This study attempts to correlate the pre- and...

Cite
Baruah RR, Bhatnagar V, Agarwala S, et al. Correlation of pre- and post-operative liver function, duct diameter at porta hepatis, and portal fibrosis with surgical outcomes in biliary atresia. J Indian Assoc Pediatr Surg. 2015;20(4):184-8doi: 10.4103/0971-9261.161040.
Baruah, R. R., Bhatnagar, V., Agarwala, S., & Gupta, S. D. (2015). Correlation of pre- and post-operative liver function, duct diameter at porta hepatis, and portal fibrosis with surgical outcomes in biliary atresia. Journal of Indian Association of Pediatric Surgeons, 20(4), 184-8. https://doi.org/10.4103/0971-9261.161040
Baruah, Rajib Ray, et al. "Correlation of pre- and post-operative liver function, duct diameter at porta hepatis, and portal fibrosis with surgical outcomes in biliary atresia." Journal of Indian Association of Pediatric Surgeons vol. 20,4 (2015): 184-8. doi: https://doi.org/10.4103/0971-9261.161040
Baruah RR, Bhatnagar V, Agarwala S, Gupta SD. Correlation of pre- and post-operative liver function, duct diameter at porta hepatis, and portal fibrosis with surgical outcomes in biliary atresia. J Indian Assoc Pediatr Surg. 2015 Oct-Dec;20(4):184-8. doi: 10.4103/0971-9261.161040. PMID: 26628810; PMCID: PMC4586981.
Copy Download .nbib Format: NLM
Serum biomarkers for acute hepatotoxicity of Echis pyramidum snake venom in rats.

International journal of clinical and experimental medicine

Asmari AK, Khan HA, Banah FA, Buraidi AA, Manthiri RA.
PMID: 25785140
Int J Clin Exp Med. 2015 Jan 15;8(1):1376-80. eCollection 2015.

Echis pyramidum is a venomous viper responsible for most cases of envenomation in Arabian Peninsula. We determined the acute phase (3-6 h) changes in serum markers of liver function including alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma glutamyl transferase...

Cite
Asmari AK, Khan HA, Banah FA, et al. Serum biomarkers for acute hepatotoxicity of Echis pyramidum snake venom in rats. Int J Clin Exp Med. 2015;8(1):1376-80
Asmari, A. K., Khan, H. A., Banah, F. A., Buraidi, A. A., & Manthiri, R. A. (2015). Serum biomarkers for acute hepatotoxicity of Echis pyramidum snake venom in rats. International journal of clinical and experimental medicine, 8(1), 1376-80.
Asmari, Abdulrahman K Al, et al. "Serum biomarkers for acute hepatotoxicity of Echis pyramidum snake venom in rats." International journal of clinical and experimental medicine vol. 8,1 (2015): 1376-80.
Asmari AK, Khan HA, Banah FA, Buraidi AA, Manthiri RA. Serum biomarkers for acute hepatotoxicity of Echis pyramidum snake venom in rats. Int J Clin Exp Med. 2015 Jan 15;8(1):1376-80. eCollection 2015. PMID: 25785140; PMCID: PMC4358595.
Copy Download .nbib Format: NLM
Omega-3 Polyunsaturated Fatty Acid for Cholestasis due to Bile Duct Paucity.

Pediatric gastroenterology, hepatology & nutrition

Bae SH, Park HS, Han HS, Yun IJ.
PMID: 25061589
Pediatr Gastroenterol Hepatol Nutr. 2014 Jun;17(2):121-4. doi: 10.5223/pghn.2014.17.2.121. Epub 2014 Jun 30.

Omega (ω)-3 polyunsaturated fatty acids appear to be effective in preventing and treating parenteral nutrition-associated liver disease, and several mechanisms were proposed for this observation. An 8-week-old male infant with cholestasis and acholic stool was diagnosed non-syndromic intrahepatic interlobular...

Cite
Bae SH, Park HS, Han HS, et al. Omega-3 Polyunsaturated Fatty Acid for Cholestasis due to Bile Duct Paucity. Pediatr Gastroenterol Hepatol Nutr. 2014;17(2):121-4doi: 10.5223/pghn.2014.17.2.121.
Bae, S. H., Park, H. S., Han, H. S., & Yun, I. J. (2014). Omega-3 Polyunsaturated Fatty Acid for Cholestasis due to Bile Duct Paucity. Pediatric gastroenterology, hepatology & nutrition, 17(2), 121-4. https://doi.org/10.5223/pghn.2014.17.2.121
Bae, Sun Hwan, et al. "Omega-3 Polyunsaturated Fatty Acid for Cholestasis due to Bile Duct Paucity." Pediatric gastroenterology, hepatology & nutrition vol. 17,2 (2014): 121-4. doi: https://doi.org/10.5223/pghn.2014.17.2.121
Bae SH, Park HS, Han HS, Yun IJ. Omega-3 Polyunsaturated Fatty Acid for Cholestasis due to Bile Duct Paucity. Pediatr Gastroenterol Hepatol Nutr. 2014 Jun;17(2):121-4. doi: 10.5223/pghn.2014.17.2.121. Epub 2014 Jun 30. PMID: 25061589; PMCID: PMC4107220.
Copy Download .nbib Format: NLM
Giant Splenorenal Shunt in a Young Patient with Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome and Portal Vein Thrombosis.

Case reports in radiology

Chegai F, Cavallo AU, Forcina M, Giuricin V, Castellani F, Greco L, Manuelli M, Manzia TM, Sergiacomi G.
PMID: 28316856
Case Rep Radiol. 2017;2017:2167364. doi: 10.1155/2017/2167364. Epub 2017 Feb 20.

We present a case of giant Splenorenal Shunt (SRS) associated with portal vein thrombosis in a 37-year-old woman with a twelve-year history of autoimmune hepatitis/primary biliary cholangitis overlap syndrome. At the moment of the CT examination laboratory tests showed...

Cite
Chegai F, Cavallo AU, Forcina M, et al. Giant Splenorenal Shunt in a Young Patient with Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome and Portal Vein Thrombosis. Case Rep Radiol. 2017;2017:2167364doi: 10.1155/2017/2167364.
Chegai, F., Cavallo, A. U., Forcina, M., Giuricin, V., Castellani, F., Greco, L., Manuelli, M., Manzia, T. M., & Sergiacomi, G. (2017). Giant Splenorenal Shunt in a Young Patient with Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome and Portal Vein Thrombosis. Case reports in radiology, 20172167364. https://doi.org/10.1155/2017/2167364
Chegai, F, et al. "Giant Splenorenal Shunt in a Young Patient with Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome and Portal Vein Thrombosis." Case reports in radiology vol. 2017 (2017): 2167364. doi: https://doi.org/10.1155/2017/2167364
Chegai F, Cavallo AU, Forcina M, Giuricin V, Castellani F, Greco L, Manuelli M, Manzia TM, Sergiacomi G. Giant Splenorenal Shunt in a Young Patient with Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome and Portal Vein Thrombosis. Case Rep Radiol. 2017;2017:2167364. doi: 10.1155/2017/2167364. Epub 2017 Feb 20. PMID: 28316856; PMCID: PMC5337847.
Copy Download .nbib Format: NLM
Risk Factors for Sensorineural Hearing Loss Among High-Risk Infants in Golestan Province, Iran in 2010 - 2011.

Iranian Red Crescent medical journal

Alaee E, Sirati M, Taziki MH, Fouladinejad M.
PMID: 26759724
Iran Red Crescent Med J. 2015 Dec 20;17(12):e20419. doi: 10.5812/ircmj.20419. eCollection 2015 Dec.

BACKGROUND: Hearing impairment, as one of the most common birth defects, is a hidden disability with negative impacts on speech and cognitive development.OBJECTIVES: The aim of this study was to assess the prevalence of sensorineural hearing loss (SNHL) and...

Cite
Alaee E, Sirati M, Taziki MH, et al. Risk Factors for Sensorineural Hearing Loss Among High-Risk Infants in Golestan Province, Iran in 2010 - 2011. Iran Red Crescent Med J. 2015;17(12):e20419doi: 10.5812/ircmj.20419.
Alaee, E., Sirati, M., Taziki, M. H., & Fouladinejad, M. (2015). Risk Factors for Sensorineural Hearing Loss Among High-Risk Infants in Golestan Province, Iran in 2010 - 2011. Iranian Red Crescent medical journal, 17(12), e20419. https://doi.org/10.5812/ircmj.20419
Alaee, Ehsan, et al. "Risk Factors for Sensorineural Hearing Loss Among High-Risk Infants in Golestan Province, Iran in 2010 - 2011." Iranian Red Crescent medical journal vol. 17,12 (2015): e20419. doi: https://doi.org/10.5812/ircmj.20419
Alaee E, Sirati M, Taziki MH, Fouladinejad M. Risk Factors for Sensorineural Hearing Loss Among High-Risk Infants in Golestan Province, Iran in 2010 - 2011. Iran Red Crescent Med J. 2015 Dec 20;17(12):e20419. doi: 10.5812/ircmj.20419. eCollection 2015 Dec. PMID: 26759724; PMCID: PMC4707290.
Copy Download .nbib Format: NLM
Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors.

World journal of gastrointestinal surgery

Abd ElWahab M, El Nakeeb A, El Hanafy E, Sultan AM, Elghawalby A, Askr W, Ali M, Abd El Gawad M, Salah T.
PMID: 27358676
World J Gastrointest Surg. 2016 Jun 27;8(6):436-43. doi: 10.4240/wjgs.v8.i6.436.

AIM: To determine predictors of long term survival after resection of hilar cholangiocarcinoma (HC) by comparing patients surviving > 5 years with those who survived < 5 years.METHODS: This is a retrospective study of patients with pathologically proven HC...

Cite
Abd ElWahab M, El Nakeeb A, El Hanafy E, et al. Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg. 2016;8(6):436-43doi: 10.4240/wjgs.v8.i6.436.
Abd ElWahab, M., El Nakeeb, A., El Hanafy, E., Sultan, A. M., Elghawalby, A., Askr, W., Ali, M., Abd El Gawad, M., & Salah, T. (2016). Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World journal of gastrointestinal surgery, 8(6), 436-43. https://doi.org/10.4240/wjgs.v8.i6.436
Abd ElWahab, Mohamed, et al. "Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors." World journal of gastrointestinal surgery vol. 8,6 (2016): 436-43. doi: https://doi.org/10.4240/wjgs.v8.i6.436
Abd ElWahab M, El Nakeeb A, El Hanafy E, Sultan AM, Elghawalby A, Askr W, Ali M, Abd El Gawad M, Salah T. Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg. 2016 Jun 27;8(6):436-43. doi: 10.4240/wjgs.v8.i6.436. PMID: 27358676; PMCID: PMC4919711.
Copy Download .nbib Format: NLM
[Not Available].

Therapie

Solas C, Muret P.
PMID: 27393201
Therapie. 2011 May-Jun;66(3):213-9. doi: 10.2515/therapie/2011032.

The HIV protease inhibitor atazanavir presents a wide inter-individual variability related to an intense hepatic metabolism. Dose-dependant elevations of bilirubin have been frequently reported with atazanavir. Relative to literature, the atazanavir therapeutic drug monitoring can it be proposed? In...

Cite
Solas C, Muret P. Niveau de preuve du suivi therapeutique pharmacologique de l'atazanavir. [Not Available]. Therapie. 2011;66(3):213-9doi: 10.2515/therapie/2011032.
Solas, C., Muret, P. (2011). Niveau de preuve du suivi therapeutique pharmacologique de l'atazanavir. [Not Available]. Therapie, 66(3), 213-9. https://doi.org/10.2515/therapie/2011032
Solas, Caroline, et al. "Niveau de preuve du suivi therapeutique pharmacologique de l'atazanavir." [Not Available]. Therapie vol. 66,3 (2011): 213-9. doi: https://doi.org/10.2515/therapie/2011032
Solas C, Muret P. Niveau de preuve du suivi therapeutique pharmacologique de l'atazanavir. [Not Available]. Therapie. 2011 May-Jun;66(3):213-9. doi: 10.2515/therapie/2011032. French. PMID: 27393201.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 4486 entries